Cite

HARVARD Citation

    Heijnsdijk, E. et al. (2020). Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer. Journal of the National Cancer Institute. pp. 1013-1020. [Online]. 
  
Back to record